Ramnarian Kajal, Paken Jessica
Department of Audiology, Faculty of Health Sciences, University of KwaZulu-Natal, Durban.
S Afr J Commun Disord. 2024 Nov 25;71(1):e1-e15. doi: 10.4102/sajcd.v71i1.1064.
Platinum-based chemotherapy poses a risk of ototoxic hearing loss, the effects of which can be devastating in paediatrics with cancer. Childhood hearing loss significantly impacts speech and language acquisition, and educational, psychosocial and emotional development, consequently negatively impacting quality of life. Adequate knowledge and effective management by healthcare professionals in the team managing paediatrics with cancer are, therefore, pivotal to mitigating the severity and impact on quality of life.
To describe the knowledge and practices of healthcare professionals on the management of ototoxic hearing loss in children receiving platinum-based chemotherapy drugs.
Using a descriptive survey design, data were collected from self-administered questionnaires completed by 74 healthcare professionals from two hospitals in KwaZulu-Natal, South Africa.
While 45 participants (60.8%) identified ototoxicity as a side effect of platinum-based chemotherapeutic drugs, 43 (58.1%) identified dose, duration and mode of administration as risk factors, and 43 participants (72.9%) did not know the duration of an ototoxicity monitoring programme post-treatment. Fifty participants (68%) accurately identified most of their roles within the ototoxicity monitoring programme. Most participants (n = 73; 99%) did not fully adhere to Health Professions Council of South Africa (HPCSA) ototoxicity monitoring guidelines. However, a positive outcome was that 70 participants (94.6%) acknowledged the importance of the ototoxicity monitoring programme for children receiving platinum-based chemotherapy.
The current study demonstrates a clear correlation between healthcare professionals' practices and their level of knowledge. These findings underscore the importance of improving the knowledge base of healthcare professionals involved in ototoxicity monitoring programme to enhance their practices effectively.Contribution: This study identified areas requiring improvement in managing ototoxicity in this patient group, prompting the inclusion of ototoxicity training. This study supports audiologists in effectively implementing and overseeing ototoxicity monitoring programme.
铂类化疗存在导致耳毒性听力损失的风险,这对患癌儿童的影响可能是毁灭性的。儿童听力损失会显著影响言语和语言习得,以及教育、心理社会和情感发展,进而对生活质量产生负面影响。因此,在管理患癌儿童的医疗团队中,医护人员具备足够的知识并进行有效管理对于减轻严重程度和对生活质量的影响至关重要。
描述医护人员对接受铂类化疗药物的儿童耳毒性听力损失管理的知识和实践。
采用描述性调查设计,通过来自南非夸祖鲁 - 纳塔尔省两家医院的74名医护人员自行填写问卷收集数据。
虽然45名参与者(60.8%)将耳毒性识别为铂类化疗药物的副作用,43名(58.1%)将剂量、疗程和给药方式识别为风险因素,但43名参与者(72.9%)不知道治疗后耳毒性监测计划的时长。50名参与者(68%)准确识别了他们在耳毒性监测计划中的大部分职责。大多数参与者(n = 73;99%)未完全遵守南非卫生专业人员委员会(HPCSA)的耳毒性监测指南。然而,一个积极的结果是70名参与者(94.6%)承认耳毒性监测计划对接受铂类化疗的儿童的重要性。
当前研究表明医护人员的实践与他们的知识水平之间存在明显关联。这些发现强调了提高参与耳毒性监测计划的医护人员的知识基础以有效改进其实践的重要性。贡献:本研究确定了该患者群体耳毒性管理中需要改进的领域,促使纳入耳毒性培训。本研究支持听力学家有效实施和监督耳毒性监测计划。